Keyword Analysis & Research: peds
Keyword Research: People who searched peds also searched
Search Results related to peds on Search Engine
-
From the Academy: Gene therapy - PubMed Central (PMC)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34169/
Nov 25, 1997 . From the Academy Gene therapy. ... there have been a number of technological breakthroughs that have allowed for clinical trials in gene therapy to be initiated. In combination with the genome initiative, the potential for new therapeutics is limitless. ... (single-gene) disorders, but it has become clear that the gene can be considered a new ...
DA: 25 PA: 87 MOZ Rank: 60
-
Gene Therapy – TMA – Translational Medicine Academy
https://www.tmacademy.org/gene-therapy/
Gene Therapy is a fast growing field with therapeutic options already available for clinicians and patients. A review of ongoing clinical trials shows the extreme dynamism of clinical research. Around 200 clinical trials are ongoing in almost 80 diseases. The therapeutic applications encompass almost all medical fields.
DA: 19 PA: 64 MOZ Rank: 81
-
Gene therapy (practice) | Khan Academy
https://www.khanacademy.org/science/in-in-class-12-biology-india/xc09ed98f7a9e671b:biotechnology-and-its-applications/xc09ed98f7a9e671b:transgenics/e/gene-therapy
Gene therapy. Adenosine deaminase (ADA) deficiency is usually detected in young children within the first two years of life, who usually suffer from widespread rashes, pneumonia, and frequent ear infections. These issues are due to poor immune function caused by ADA deficiency.
DA: 78 PA: 17 MOZ Rank: 21
-
Gene therapy using retroviruses (practice) | Khan Academy
https://www.khanacademy.org/test-prep/mcat/biological-sciences-practice/biological-sciences-practice-tut/e/gene-control---passage-1
Practice: Gene therapy using retroviruses. This is the currently selected item. Practice: Regulation of the lac operon. Practice: Mutations that cause Crohn’s Disease. Practice: Genetics of Myotonic dystrophy. Practice: Inheritance patterns in flowering plants. Practice: Selective pressures on cacti needle length.
DA: 10 PA: 41 MOZ Rank: 67
-
International Summit on Human Gene Editing: A Global
https://www.ncbi.nlm.nih.gov/sites/books/NBK343651/
To explore the many questions surrounding the use of gene editing tools in humans, the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, the Royal Society, and the Chinese Academy of Sciences hosted a three-day international summit on December 1-3, 2015, in Washington, DC.
DA: 32 PA: 28 MOZ Rank: 52
-
What is Gene Therapy? | FDA
https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy
Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use 1.. …
DA: 70 PA: 31 MOZ Rank: 98
-
FLT180a: Next generation AAV vector for ... - academy.isth.org
https://academy.isth.org/isth/2019/melbourne/263496/jonathan.foley.flt180a.next.generation.aav.vector.for.haemophilia.b.-.long.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D1497%2Atopic%3D21457%2Aot_id%3D20800
Category: Hemophilia Gene Therapy Background: FLT180a is a recombinant adeno-associated virus (AAV) vector with a human liver-tropic engineered capsid (AAVS3) expressing a gain-of-function variant (R338L/Padua) of human factor IX (FIX) under the control of a liver-specific promoter (FRE1).
DA: 6 PA: 15 MOZ Rank: 21
-
Home espace - TMA - Translational Medicine Academy
https://www.tmacademy.org/
Gene Therapy is a fast growing field with therapeutic options already available for clinicians and patients. A review of ongoing clinical trials shows the extreme dynamism of clinical research. Around 200 clinical trials are ongoing in almost 80 diseases. The therapeutic applications encompass almost all medical fields. Gene therapy has the ...
DA: 63 PA: 68 MOZ Rank: 55
-
Publication: An overview of current cell and gene therapy
https://www.eb-haus.org/en/research-study-centre/research-news/publication-an-overview-of-current-cell-and-gene-therapy-approaches-for-inherited-skin-diseases/
These studies made clear that the success of a therapy depends on the individual characteristics of the patient. The currently most promising personalized ex vivo gene therapy uses the modern and virus-free gene editing method CRISPR. Until its clinical application, however, assessments of safety and efficacy are still required.
DA: 53 PA: 16 MOZ Rank: 96
-
Cell & Gene Therapy Workshop - Parexel Academy
https://parexel-academy.com/ja/cell-gene-therapy-workshop/
Cell & Gene Therapy Workshop - Parexel Academy. Thank you for attending our Workshop on “Cell and Gene Therapy – from Bench to Bedside”. As discussed, we are happy to share the presentations. Should you have any questions or require further information, please get in touch.
DA: 6 PA: 17 MOZ Rank: 95
-
First-in-human Evidence of Durable ... - ISTH Academy
https://academy.isth.org/isth/2019/melbourne/274198/k.john.pasi.first-in-human.evidence.of.durable.therapeutic.efficacy.and.safety.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dvaloctocogene+roxaparvovec
First-in-human Evidence of Durable Therapeutic Efficacy and Safety of AAV Gene Therapy Over Three-years with Valoctocogene Roxaparvovec for Severe Haemophilia A (BMN 270-201 Study) ISTH Academy. Pasi J. 07/08/19; 274198; LB 01.2 Topic: Hemophilia Gene Therapy
DA: 91 PA: 1 MOZ Rank: 21
-
Gene Therapy: Transitioning from Proof of Principle to
https://www.optumhealtheducation.com/disease-management/anc-gene-2020
Hundreds of research studies (clinical trials) are under way to test gene therapy as a treatment for genetic conditions, cancer, and HIV/AIDS, and the number of approvals in the U.S. is expected to increase substantially in future years. This session will explore the current and future application of gene therapy. Provided by
DA: 57 PA: 14 MOZ Rank: 7
-
History of gene therapy - ScienceDirect
https://www.sciencedirect.com/science/article/pii/S0378111913004344
Aug 10, 2013 . The European Medicines Agency (EMA) defines that a gene therapy medicinal product is a biological medicinal product which fulfils the following two characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic acid used in or administered to human beings with a view to regulating, repairing, replacing, adding or …
DA: 19 PA: 83 MOZ Rank: 12
-
Guangping Gao, PhD - Kriya Therapeutics
https://generatedesignstaging.com/kriya/team/guangping-gao-phd/
Mar 30, 2021 . Guangping Gao, PhD Scientific Advisor Dr. Gao is Co-Director of the Li Weibo Institute for Rare Diseases Research, Director of the Horae Gene Therapy Center and Viral Vector Core, Professor of Microbiology and Physiological Systems, and Penelope Booth Rockwell Professor in Biomedical Research at the University of Massachusetts Medical School. Dr. Gao …
DA: 81 PA: 27 MOZ Rank: 61
-
Advanced Therapy Medicinal Products Development | Training
https://lsacademy.com/en/product/regulatory-and-scientific-pathways-for-global-advanced-therapy-medicinal-products-development-atmps-2/
Advanced therapy medicinal products (ATMPs) are currently undergoing a boom. Several products including viral, non-viral and cell-based products have forged a path to market. In their wake, academics and clinicians continue to lead innovation and unlock the clinical potential of new approaches and technologies, whereas increased industry interest is stimulating …
DA: 72 PA: 19 MOZ Rank: 1
-
Gene therapy shows promise in tackling common cause of
https://www.healthcanal.com/eyes-vision/250068-gene-therapy-shows-promise-in-tackling-common-cause-of-childhood-blindness.html
Feb 26, 2020 . Gene therapy using viral vectors to deliver a healthy copy of a mutated gene into affected cells aims to slow down the degeneration and preserve visual function. However, the RPGR gene has an unusual genetic code which makes it unstable to work with in the laboratory and until now difficult to translate into human trials.
DA: 26 PA: 86 MOZ Rank: 54
-
Mark A. Kay, MD, PhD - Kriya Therapeutics
https://generatedesignstaging.com/kriya/team/mark-a-kay-md-phd/
Mar 30, 2021 . Dr. Kay is one of the founders of the American Society of Gene Therapy and served as the President in 2005-2006. He has organized many national and international conferences including the first Gordon Conference related to gene therapy. He was elected to the American Academy of Pediatrics in 2010.
DA: 83 PA: 58 MOZ Rank: 76
-
Clear Victory - ELLE
https://www.elle.com/beauty/makeup-skin-care/tips/a2464/how-to-cure-adult-acne-580446/
Sep 14, 2011 . Clear Victory Braces and angst are two things most of us can happily leave behind in our adolescence; acne, less so. In fact, breakouts are seemingly becoming more common later in life: Studies ...
DA: 72 PA: 7 MOZ Rank: 74
-
RPGR and X-linked Retinitis Pigmentosa | Cideciyan Lab
https://www.med.upenn.edu/cideciyanlab/rpgr.html
Jan 24, 2021 . Successful experiments in gene augmentation therapy at different disease stages of dogs with RPGR-ORF15 mutations have set a clear path for clinical trials of gene augmentation therapy in patients. Cideciyan Lab has been involved with better understanding and potentially treating XLRP for over 25 years.
DA: 93 PA: 53 MOZ Rank: 44